Article Sidebar

Submitted
July 2, 2021
Accepted
December 9, 2021
Published
December 31, 2021
Download
PDF
Statistic
Read Counter : 554 Download : 611

Main Article Content

Abstract

Background: The COVID-19 virus has spread throughout the world and has been declared as a global pandemic by WHO. Some population groups are more susceptible to COVID-19, and one of them is pregnant women. Pregnancy increases risks of the COVID-19, especially thrombotic complications. The SARS-CoV-2 infection may vary widely from asymptomatic to severe infection. Some studies have shown that ABO blood group can be a marker of susceptibility to some disease progression.
Objective:This study aims to investigate relationships between the ABO blood group, the COVID-19 infection and its complications in pregnant women at Dr. Moewardi Hospital, Surakarta.
Methods: This study was an observational analytic study with a cross-sectional study design involving 40 pregnant women infected with COVID-19 at Dr. Moewardi Hospital, Surakarta. COVID-19 PCR swabs on the women were administered on their oropharynx and nasopharynx, and laboratory examination of the ABO blood group in all samples was performed. Comparative data distribution of blood groups in the population and the global population distribution were calculated by Chi Square Goodness of Fit. Comparative data between ABO blood group distributions, blood parameters and complications (respiratory, thrombotic, other infections, and death) were calculated by Chi square test and then by One-Way ANOVA. Next, correlation tests for the complications of the blood group and the ages applied a multinomial regression.
Results: There were significant differences of thrombotic complications on the blood group of pregnant women infected with COVID-19 (p=0.027). Blood type B significantly tended to experience thrombotic complications when compared to other blood groups (p=0.022).
Conclusion: The ABO blood group could affect the complication levels in the pregnant women infected with the COVID 19.

Keywords

ABO blood group pregnancy COVID-19

Article Details

License

Authors who publish in the Jurnal Kedokteran dan Kesehatan Indonesia agree to the following terms:

  1. Authors retain copyright and grant Jurnal Kedokteran dan Kesehatan Indonesia right of first publication with the work simultaneously licensed under a Creative Commons Attribution Licence that allows others to adapt (remix, transform, and build) upon the work non-commercially with an acknowledgement of the work's authorship and initial publication in Jurnal Kedokteran dan Kesehatan Indonesia.
  2. Authors are permitted to share (copy and redistribute) the journal's published version of the work non-commercially (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in Jurnal Kedokteran dan Kesehatan Indonesia.
Author Biographies

Sri Sulistyowati, Department of Obstetrics and Gynaecology, Faculty of Medicine, Universitas Sebelas Marety/Universitas Sebelas Maret Hospital, Surakarta

Obstetrics and dan Gynekology Department UNS Hospital/ Medical Faculty Sebelas Maret University

Nutria Widya Purna Anggraini, Department of Obstetrics and Gynaecology, Faculty of Medicine, Universitas Sebelas Maret/Dr. Moewardi General Hospital, Surakarta

Faculty of Medicine, Sebelas Maret University, Surakarta, Indonesia

Soetrisno Soetrisno, Department of Obstetrics and Gynaecology, Faculty of Medicine, Universitas Sebelas Maret/Universitas Sebelas Maret Hospital, Surakarta

Obstetrics and  Gynekology Department UNSi Hospital

universitas sebelas maret

Eric Edwin Yuliantara, Department of Obstetrics and Gynaecology, Faculty of Medicine, Universitas Sebelas Maret/Dr. Moewardi General Hospital, Surakarta

Obstetrics and  Gynekology Department UNSi Hospital

universitas sebelas maret

Supriyadi Hari Respati, Department of Obstetrics and Gynaecology, Faculty of Medicine, Universitas Sebelas Maret/Dr. Moewardi General Hospital, Surakarta

Obstetrics and dan Gynekology Department Dr Moewardi Hospital/

Muhammad Adrianes Bachnas, Department of Obstetrics and Gynaecology, Faculty of Medicine, Universitas Sebelas Maret/Dr. Moewardi General Hospital, Surakarta

Obstetrics and dan Gynekology Department Dr Moewardi Hospital/

Wisnu Prabowo, Department of Obstetrics and Gynaecology, Faculty of Medicine, Universitas Sebelas Maret/Dr. Moewardi General Hospital, Surakarta

Obstetrics and dan Gynekology Department Dr Moewardi Hospital

Hafi Nurinasari, Department of Obstetrics and Gynaecology, Faculty of Medicine, Universitas Sebelas Maret/Universitas Sebelas Maret Hospital, Surakarta

Obstetrics and dan Gynekology Department Dr Moewardi Hospital/

Dympna Pramelita, Department of Obstetrics and Gynaecology, Faculty of Medicine, Universitas Sebelas Maret/Universitas Sebelas Maret Hospital, Surakarta

Obstetrics and dan Gynekology Department Dr Moewardi Hospital/

Dewi Setiyawati, Department of Obstetrics and Gynaecology, Faculty of Medicine, Universitas Sebelas Maret/Universitas Sebelas Maret Hospital, Surakarta

Obstetrics and dan Gynekology Department Dr Moewardi Hospital/

Metharisa Sujana, Department of Obstetrics and Gynaecology, Faculty of Medicine, Universitas Sebelas Maret/Universitas Sebelas Maret Hospital, Surakarta

Obstetrics and dan Gynekology Department Dr Moewardi Hospital/

Aldi Firmansyah, Department of Obstetrics and Gynaecology, Faculty of Medicine, Universitas Sebelas Maret/Universitas Sebelas Maret Hospital, Surakarta

Obstetrics and dan Gynekology Department Dr Moewardi Hospital/

How to Cite
Sulistyowati, S., Anggraini, N. W. P., Soetrisno, S., Yuliantara, E. E., Respati, S. H., Bachnas, M. A., Prabowo, W., Nurinasari, H., Pramelita, D., Setiyawati, D., Sujana, M., & Firmansyah, A. (2021). The effect of ABO blood group on COVID-19 in pregnancy. JKKI : Jurnal Kedokteran Dan Kesehatan Indonesia, 12(3), 233–241. https://doi.org/10.20885/JKKI.Vol12.Iss3.art6
Download Citation
Endnote/Zotero/Mendeley (RIS)
BibTeX

References

  1. Salzberger B, Glück T, Ehrenstein B. Successful containment of COVID-19: the WHO-Report on the COVID-19 outbreak in China. Infection. 2020;48(2):151–3.
  2. Rothan HA, Byrareddy SN. The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak. J Autoimmun [Internet]. 2020;109(March):102433. Available from: https://doi.org/10.1016/j.jaut.2020.102433
  3. Price LC, McCabe C, Garfield B, Wort SJ. Thrombosis and COVID-19 pneumonia: The clot thickens! Eur Respir J [Internet]. 2020;56(1). Available from: http://dx.doi.org/10.1183/13993003.01608-2020
  4. Docherty AB, Harrison EM, Green CA, Hardwick HE, Pius R, Norman L, et al. Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: Prospective observational cohort study. BMJ. 2020;369(March):1–12.
  5. Townsend MJ, Kyle TK, Stanford FC. Outcomes of COVID-19: disparities in obesity and by ethnicity/race. Int J Obes [Internet]. 2020;44(9):1807–9. Available from: http://dx.doi.org/10.1038/s41366-020-0635-2
  6. Wastnedge EAN, Reynolds RM, van Boeckel SR, Stock SJ, Denison FC, Maybin JA, et al. Pregnancy and COVID-19. Physiol Rev. 2021 Jan;101(1):303–18.
  7. Ahmed I, Azhar A, Eltaweel N, Tan BK. First COVID-19 maternal mortality in the UK associated with thrombotic complications. Br J Haematol. 2020;190(1):e37–8.
  8. Groot HE, Sierra LEV, Said MA, Lipsic E, Karper JC, Van Der Harst P. Genetically determined ABO blood group and its associations with health and disease. Arterioscler Thromb Vasc Biol. 2020;(March):830–8.
  9. Mor G, Cardenas I, Abrahams V, Guller S. Inflammation and pregnancy: The role of the immune system at the implantation site. Ann N Y Acad Sci. 2011;1221(1):80–7.
  10. Cheng Y, G C, CH C. ABO Blood Group and Susceptibility to Severe Acute Respiratory Syndrome. JAMA Psychiatry. 2016;73(1):87–8.
  11. Sano R, Nakajima T, Takahashi Y, Kubo R, Kobayashi M, Takahashi K, et al. Epithelial expression of human ABO blood group genes is dependent upon a downstream regulatory element functioning through an epithelial cell-specific transcription Factor, Elf5. J Biol Chem. 2016;291(43):22594–606.
  12. Akashi T, Watanabe A, Komiya A, Fuse H. Evaluation of the Sperm Motility Analyzer System (SMAS) for the assessment of sperm quality in infertile men. Syst Biol Reprod Med. 2010;56(6):473–7.
  13. Agarwal A, Said TM. Role of sperm chromatin abnormalities and DNA damage in male infertility. Hum Reprod Update. 2003;9(4):331–45.
  14. Ahmed B, Vaidyanathan G, Arumughan Pillai S, AlSabti J, Khaduri M Al, Pathare A. Factors Influencing the Success Rate of Intrauterine Insemination: ARetrospective Study in Sultan Qaboos University Hospital. J Women’s Heal Care. 2017;06(05).
  15. Bishop P. Fertility treatment. New Civ Eng. 1993;1064(March):16–7.
  16. Ramanathan K, Antognini D, Combes A, Paden M, Zakhary B, Ogino M, et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet. 2020;2020(January):19–21.
  17. Zhao J, Yang Y, Huang H, Li D, Gu D, Lu X, et al. Relationship between the ABO Blood Group and the COVID-19 Susceptibility. medRxiv. 2020;
  18. Zietz M, Zucker J, Tatonetti NP. Testing the association between blood type and COVID-19 infection, intubation, and death. medRxiv. 2020;1–27.
  19. Cooling L. Blood groups in infection and host susceptibility. Clin Microbiol Rev. 2015;28(3):801–70.
  20. Johnson KD, Harris C, Cain JK, Hummer C, Goyal H, Perisetti A. Pulmonary and Extra-Pulmonary Clinical Manifestations of COVID-19. Front Med. 2020;7(December 2019):1–12.
  21. Helms J, Tacquard C, Severac F, Leonard-Lorant I, Ohana M, Delabranche X, et al. High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study. Intensive Care Med [Internet]. 2020;46(6):1089–98. Available from: https://doi.org/10.1007/s00134-020-06062-x
  22. Ventura-Díaz S, Quintana-Pérez J V., Gil-Boronat A, Herrero-Huertas M, Gorospe-Sarasúa L, Montilla J, et al. A higher D-dimer threshold for predicting pulmonary embolism in patients with COVID-19: a retrospective study. Emerg Radiol. 2020 Dec;27(6):679–89.
  23. Cai J, Zhang H, Tang M. Infection and thrombosis associated with COVID-19: Possible role of the ABO blood group – Letter to the Editor. Med Clin (Barc). 2021;155(8):340–3.
  24. Bommanavar S, Smitha T. ABO blood grouping and COVID 19: Is there any correlation in suspectibility? J Oral Maxillofac Pathol. 2020;
  25. Guillon P, Clément M, Sébille V, Rivain JG, Chou CF, Ruvoën-Clouet N, et al. Inhibition of the interaction between the SARS-CoV Spike protein and its cellular receptor by anti-histo-blood group antibodies. Glycobiology. 2008;18(12):1085–93.
  26. Zalba Marcos S, Antelo ML, Galbete A, Etayo M, Ongay E, García-Erce JA. Infection and thrombosis associated with COVID-19: Possible role of the ABO blood group. Med Clínica (English Ed. 2020 Oct;155(8):340–3.